Abstract
At the time of writing this column the most talked about issue was the court case between Matthias Rath and the treatment action campaign (TAC). The TAC and Rath were involved in a legal battle over the controversial dissident's widely publicized claims that the TAC is a front for the pharmaceutical industry.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
